Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Lovelace Biomedical Research Institute
EIR
•Lovelace Biomedical Research Institute•September 13, 2019

Lovelace Biomedical Research Institute – FDA EIR, Sep 13, 2019

Record Details

Lovelace Respiratory Research Institute underwent an unannounced routine Good Laboratory Practice (GLP) inspection by the FDA from September 9-13, 2019, conducted under Compliance Program 7348.808 for nonclinical laboratories. The inspection verified that corrective actions from a previous 2016 inspection had been implemented. However, the current inspection identified two main observations issued on Form FDA 483. First, the study director failed to ensure accurate recording and verification of experimental data, specifically lacking documentation to confirm test article stability during dosing for two GLP studies. Second, the Quality Assurance Unit did not maintain a master schedule sheet with all required elements for nonclinical laboratory studies; this was noted as a repeat violation from the 2016 inspection.

Additional discussion items raised with management included inadequate separation of GLP/non-GLP, and test/control articles and their formulations; insufficient removal of expired test and control articles; incomplete documentation in HPLC user logs regarding performance checks; and inadequate labeling of test articles, particularly missing expiration dates. Management acknowledged the findings and committed to responding to the FDA 483 observations within 15 working days.

Company
Lovelace Biomedical Research Institute
Inspection date
September 13, 2019
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Zhou Chen (issuing_officer)
  • Philip J. Kuehl (company_representative)
  • Jacob D. McDonald (recipient)
  • Dustin Tran (Investigator )
  • Gensheng Wang (company_representative)
View Company Profile

ID · 5b2bd139-86c9-4bdd-af30-792f94524848

Violation Codes5
21 CFR 58.8121 CFR 58.33(b)21 CFR 820.5021 CFR 31221 CFR 58.35(b)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Lovelace Biomedical Research Institute
  • WARNING_LETTER - 2025-04-18April 18, 2025
  • 483 - 2025-04-18April 18, 2025
  • EIR - 2020-01-31January 31, 2020
  • 483 - 2020-01-27January 27, 2020
  • 483 - 2019-09-13September 13, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lovelace Biomedical Research Institute
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.